David A. Koss

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure–activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog

Subas M. Sakya, Kristin M. Lundy DeMello, Martha L. Minich et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine

Jin Li, Kristin M. Lundy DeMello, Henry S. Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure–activity relationship studies of 5-alkylethers and 5-thioethers

Subas M. Sakya, Hengmiao Cheng, Kristin M. Lundy DeMello et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The structure of CP-80,219, a new polyether antibiotic related to dianemycin.

John P. Dirlam, LAURA PRESSEAU-LINABURY, David A. Koss · The Journal of Antibiotics · 1990 · 17 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +5

Synthetic modification of a novel microbial ionophore: exploration of anticoccidial structure-activity relationships

Edward A. Glazer, David A. Koss, Olson Ja et al. · Journal of Medicinal Chemistry · 1992 · 17 citations

Pharmacy, Medicinal Chemistry, Microbiology +14